Skip to search formSkip to main contentSkip to account menu

Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor [EPC]

Known as: HCV Non-Nucleoside NS5B Palm Polymerase Inhibitor, Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Hepatitis C virus (HCV) genotype 4 is highly heterogeneous. HCV subtype 4r has been suggested to be less responsive to direct… 
Review
2019
Review
2019
OBJECTIVE We performed a descriptive study of patients who have failed to DDAs in our Veteran population. The primary outcome of… 
2018
2018
Objective The present study aimed to reveal the factors associated with virologic failure in sofosbuvir and ledipasvir (SOF/LDV… 
2016
2016
Sofosbuvir (SOF), a nucleotide analog pro‐drug, targets hepatitis C virus (HCV) NS5B polymerase and shows potential for treating… 
2016
2016
Jun Ito, Goki Suda, Yoshiya Yamamoto, Atsushi Nagasaka, Ken Furuya, Kenichi Kumagai, Hideaki Kikuchi, Takuto Miyagishima, Tomoe… 
2014
2014
Hepatitis C virus (HCV) protease inhibitors (PIs) and polymerase inhibitors: nucleos(t)ide inhibitors (NS5B‐NIs) and non‐nucleos… 
2013
2013
  • A. Geier
  • MMW - Fortschritte der Medizin
  • 2013
  • Corpus ID: 75840833
Mit den Proteaseinhibitoren der ersten Generation konnten in einer Triple-Therapie mit PEG-Interferon bei HCV-Patienten Genotyp 1… 
2012
2012
  • G. Haqshenas
  • Journal of viral hepatitis
  • 2012
  • Corpus ID: 30727702
Summary.  Hepatitis C virus (HCV) nonstructural protein 5B (NS5B) is an RNA‐dependent RNA polymerase (RdRp) that is involved in…